Editorial
doi: 10.1183/13993003.00114-2025.
Print 2025 Jun.
Targeting the AXL pathway: a promising strategy for pulmonary fibrosis
Affiliations
- PMID: 40473304
- DOI: 10.1183/13993003.00114-2025
Item in Clipboard
Editorial
Targeting the AXL pathway: a promising strategy for pulmonary fibrosis
Eur Respir J.
.
No abstract available
Conflict of interest statement
Conflict of interest: J.L. Larson-Casey has no potential conflicts of interest to disclose. A.B. Carter has a patent issued (14262448: Methods to modulate Rac1 import and to treat pulmonary fibrosis).
Comment on
-
Inhibition of AXL ameliorates pulmonary fibrosis via attenuation of M2 macrophage polarisation.Eur Respir J. 2025 Jun 5;65(6):2400615. doi: 10.1183/13993003.00615-2024. Print 2025 Jun. Eur Respir J. 2025. PMID: 39788632 Free PMC article.
Similar articles
-
Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.Am J Respir Crit Care Med. 2018 Jun 1;197(11):1443-1456. doi: 10.1164/rccm.201707-1519OC. Am J Respir Crit Care Med. 2018. PMID: 29634284 Free PMC article.
-
Targeting the AXL Receptor in Combating Smoking-related Pulmonary Fibrosis.Am J Respir Cell Mol Biol. 2021 Jun;64(6):734-746. doi: 10.1165/rcmb.2020-0303OC. Am J Respir Cell Mol Biol. 2021. PMID: 33730527 Free PMC article.
-
Orderly Regulation of Macrophages and Fibroblasts by Axl in Bleomycin-Induced Pulmonary Fibrosis in Mice.J Cell Mol Med. 2025 Jan;29(1):e70321. doi: 10.1111/jcmm.70321. J Cell Mol Med. 2025. PMID: 39779468 Free PMC article.
-
Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer.Int J Mol Sci. 2021 Sep 15;22(18):9953. doi: 10.3390/ijms22189953. Int J Mol Sci. 2021. PMID: 34576116 Free PMC article. Review.
-
AXL receptor tyrosine kinase as a therapeutic target in NSCLC.Lung Cancer (Auckl). 2015 Apr 30;6:27-34. doi: 10.2147/LCTT.S60438. eCollection 2015. Lung Cancer (Auckl). 2015. PMID: 28210148 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
